Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

3 Oct 2017 07:00

RNS Number : 4601S
Electrocomponents PLC
03 October 2017
 

 

Electrocomponents plc has today issued a trading update ahead of publishing half-year results on 14 November 2017

 

Regions

Q1

Q2

H1 2018

 

Northern Europe

 

10%

 

13%

11%

Southern Europe

11%

12%

11%

Central Europe

11%

15%

13%

Total Europe

11%

13%

12%

Asia & Emerging Markets

18%

17%

17%

North America

16%

15%

16%

Group

13%

14%

13%

 

 

 

Our good start in Q1 has continued into Q2, as strong execution and a positive market backdrop combined to drive faster revenue growth and market share gains across all five of our regions.

· Revenue growth(1) of 13% in H1 to September 2017, with all five regions continuing to see double-digit underlying revenue growth.

o Continued strong momentum in eCommerce with 14% H1 revenue growth.

o An acceleration in growth for RS Pro, our own-brand business, in Q2 leading to growth of 10% in H1 revenue.

o Trading comparatives will toughen in H2 with underlying revenue growth(1) trends in the year to March 2017 of 2.1% in H1 and 7.5% in H2.

· We continue to make good progress on our initiatives to stabilise gross margin and now expect to see a modest improvement in gross margin for H1 compared to the previous year. We remain on track to deliver stable gross margins for the full year.

· We have invested in inventory during H1 to improve stock availability and support faster revenue growth and, as such, we expect to see a higher than normal weighting of cash flow to the second half of our year to March 2018.

· Given stronger than expected progress to date and some benefit from translational foreign exchange(2) we now expect half year headline profit before tax to be around £78m (H1 2017: £55.1m).

· We are taking advantage of the strong momentum in the business to increase investment in areas such as innovation and digital in H2 to support future growth. Consequently, we now expect to see a more even distribution of profits between H1 and H2 in the current financial year.

 

 

LEI: 549300KVXDURRKVW7R37

 

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Head of Investor Relations & Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

 

Tulchan Communications

020 73534200

 

Notes:

1) Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying sales growth/decline").

2) Our profits remain sensitive to movements in exchange rates on translation of overseas profits. Every 1 cent movement in Euro will have c. £1.2m impact on profits. Every 1 cent movement in US $ will have c. £0.4m impact on profits. We expect to see around £5m benefit to profits from sterling weakness upon translation of overseas profits during the first half using our H1 average exchange rate of 1.29 for dollar and 1.14 for euro. If 30 September rates were to persist for the balance of the year, we would see a benefit of around £5m upon translation of overseas profits for the full year. 

3) During H1, we saw an adverse impact from fewer trading days which negatively impacted revenues by around £16m. In the full year we expect around a £24m adverse impact upon revenues from fewer trading days.

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Tuesday 3rd October

UK Time:

08.00h call

Telephone number:

+44 (0) 1452 55 55 66

PIN:

90190149

Chairman:

Lindsley Ruth

Electrocomponents plc - Replay Dial in Instructions (available until Tuesday 10th October)

Telephone number:

+44 (0) 1452 55 00 00

PIN:

90190149

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUSSRBAARRAA
Date   Source Headline
1st Feb 201610:06 amRNSBlocklisting Interim Review
21st Jan 201611:34 amRNSNotice of trading update
4th Jan 20169:13 amRNSTotal Voting Rights
14th Dec 20157:00 amRNSDirectorate Change
1st Dec 201510:15 amRNSHolding(s) in Company
30th Nov 20159:31 amRNSTotal Voting Rights
25th Nov 201511:36 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSFY16 Half-year Financial Report
30th Oct 201510:16 amRNSTotal Voting Rights
9th Oct 20159:35 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSTrading Update
30th Sep 20152:43 pmRNSDirectorate Change
30th Sep 201511:55 amRNSTotal Voting Rights
24th Sep 201510:46 amRNSNotice of Trading Update
23rd Sep 201511:19 amRNSHolding(s) in Company
8th Sep 201510:47 amRNSChange of Adviser
4th Aug 20154:02 pmRNSAdditional Listing
31st Jul 201511:00 amRNSBlocklisting Interim Review
23rd Jul 20151:57 pmRNSResult of AGM
23rd Jul 20157:00 amRNSFirst Quarter Trading Statement
16th Jul 20159:16 amRNSHolding(s) in Company
6th Jul 20151:43 pmRNSDirector/PDMR Shareholding
1st Jul 20151:33 pmRNSDirector/PDMR Shareholding
30th Jun 201510:34 amRNSTotal Voting Rights
24th Jun 20153:55 pmRNSDirector/PDMR Shareholding
24th Jun 20159:53 amRNSDirector/PDMR Shareholding
19th Jun 201510:31 amRNSNotice of trading update
16th Jun 20152:54 pmRNSAnnual Financial Report
1st Jun 20159:52 amRNSHolding(s) in Company
21st May 20153:10 pmRNSDirector/PDMR Shareholding
21st May 20157:00 amRNSDirectorate Change
21st May 20157:00 amRNSFinal Results
7th May 201510:13 amRNSDirectorate Change
7th May 201510:11 amRNSDirectorate Change
30th Apr 201511:21 amRNSTotal Voting Rights
2nd Apr 20157:00 amRNSTrading Statement
1st Apr 20153:10 pmRNSDirectorate Change
31st Mar 20154:49 pmRNSDirectorate Change
31st Mar 20151:46 pmRNSTotal Voting Rights
13th Mar 20159:26 amRNSNotice of Trading Update
2nd Mar 20152:51 pmRNSDirector/PDMR Shareholding
2nd Mar 201512:24 pmRNSTotal Voting Rights
27th Feb 201510:12 amRNSDirector Declaration
27th Feb 20157:00 amRNSDirectorate Change
11th Feb 20157:00 amRNSTrading Statement
6th Feb 20153:22 pmRNSTotal Voting Rights
6th Feb 20153:01 pmRNSBlocklisting Interim Review
2nd Feb 20152:57 pmRNSBlocklisting Interim Review
2nd Feb 20152:51 pmRNSTotal Voting Rights
15th Jan 20159:47 amRNSNotice of interim management statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.